Drug Stocks to Watch for Earnings on Aug 3: ZTS, EXEL & More
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:30AM CDT
Can drug stocks Zoetis, Conatus and others pull a surprise when they report their Q2 results on Aug 3?
ZTS: 49.72 (-0.68), JNJ: 124.85 (-0.55), GILD: 79.57 (-0.89), GERN: 2.72 (+0.01), CNAT: 2.33 (+0.04), AERI: 17.34 (+0.16), EXEL: 9.15 (-0.12)
Keryx (KERX) Stock Down on Wider Q2 Loss, Supply Issues
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 8:17AM CDT
Keryx (KERX) announced disruption in the supply of Auryxia tablets along with disappointing second-quarter results.
ZTS: 49.72 (-0.68), INVA: 12.84 (-0.20), ANIP: 61.02 (-0.04), KERX: 4.30 (-0.42)
Sanofi (SNY) Posts In-Line Q2 Earnings, Revenues Down Y/Y
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 4:19PM CDT
Sanofi (SNY) reported second-quarter 2016 business earnings of 74 cents per American Depositary Share, in line with the Zacks Consensus Estimate.
ZTS: 49.72 (-0.68), INVA: 12.84 (-0.20), ANIP: 61.02 (-0.04), SNY: 41.57 (-0.92)
Zoetis (ZTS): Stock to Beat Earnings Estimates in Q2 Again
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 11:01AM CDT
Zoetis (ZTS), which is set to report second-quarter 2016 results on Aug 3, had delivered a positive earnings surprise of 17.07% last quarter.
ZTS: 49.72 (-0.68), ABT: 45.07 (-0.22), ICPT: 170.47 (+0.75), EXEL: 9.15 (-0.12)
Will TrovaGene (TROV) Pull an Earnings Surprise in Q2?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 9:11AM CDT
TrovaGene Inc. (TROV) is expected to release second-quarter 2016 results on Aug 4.
ZTS: 49.72 (-0.68), TROV: 5.56 (-0.02), ANIP: 61.02 (-0.04), GLYC: 8.50 (-0.34)
Web.com Group (WEB) Q2 Earnings: Will it Surprise Again?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 9:07AM CDT
Web.com Group, Inc. (WEB) is slated to report second-quarter 2016 results on Aug 4.
ZTS: 49.72 (-0.68), WEB: 18.58 (-0.62), LFL: 8.46 (-0.17), SLCA: 34.16 (+1.43)
Inogen (INGN) Q2 Earnings: Can the Stock Pull a Surprise?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 8:54AM CDT
Inogen Inc. (INGN) is scheduled to report second-quarter 2016 results on Aug 4.
ZTS: 49.72 (-0.68), ANIP: 61.02 (-0.04), INGN: 52.74 (-0.26), GLYC: 8.50 (-0.34)
Pacific Biosciences (PACB) Q2 Earnings: What's in Store?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 8:52AM CDT
Pacific Biosciences of California Inc. (PACB) is scheduled to report second-quarter 2016 results on Aug 4.
ZTS: 49.72 (-0.68), PACB: 8.43 (-0.19), ANIP: 61.02 (-0.04), GLYC: 8.50 (-0.34)
Will Competition Weigh on Gogo Inc.'s (GOGO) Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 8:47AM CDT
Gogo Inc. (GOGO), the leading in-flight connectivity provider, is slated to release second-quarter 2016 results on Aug 4.
ZTS: 49.72 (-0.68), GOGO: 8.50 (+0.05), LFL: 8.46 (-0.17), SLCA: 34.16 (+1.43), VSAT: 72.67 (-1.17)
What's in Store for Tableau Software (DATA) in Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 3:47PM CDT
Tableau Software, Inc. (DATA) is set to release second-quarter 2016 results on Aug 2.
ZTS: 49.72 (-0.68), EXPD: 51.29 (+1.70), DATA: 56.40 (-0.04), LFL: 8.46 (-0.17)
Fiserv (FISV) to Post Q2 Earnings: Will it Surprise Again?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 10:29AM CDT
Fiserv, Inc. (FISV), is slated to report second-quarter 2016 results on Aug 2.
ZTS: 49.72 (-0.68), FIS: 78.47 (-0.73), FISV: 109.41 (-0.94), DE: 77.70 (+0.01)
ARIAD's (ARIA) Stock Up on Q2 Earnings & Revenue Beat
Arpita Dutt - Zacks Investment Research - Fri Jul 29, 8:23AM CDT
ARIAD (ARIA) swung to earnings in the second quarter while Iclusig sales continued to grow.
ZTS: 49.72 (-0.68), INCY: 88.95 (-1.05), ARIA: 9.72 (+0.01), NKTR: 17.18 (-0.58)
Can Ecolab (ECL) Spring an Earnings Surprise in Q2?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 5:10PM CDT
Ecolab Inc. (ECL) is slated to announce second-quarter 2016 earnings results on Aug 2, 2016.
ZTS: 49.72 (-0.68), CYTR: 0.57 (-0.03), NKTR: 17.18 (-0.58), ECL: 122.81 (+4.14)
Weight Watchers (WTW) Q2 Earnings: A Surprise in Store?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:57AM CDT
Weight management service provider Weight Watchers International Inc. is scheduled to release second-quarter 2016 results on Aug 4.
ZTS: 49.72 (-0.68), CYTR: 0.57 (-0.03), WTW: 10.69 (-0.46), NKTR: 17.18 (-0.58)
Can Zoetis (ZTS) Keep the Earnings Streak Alive This Quarter?
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 7:39AM CDT
Zoetis could be a great candidate for another beat as it has seen a nice streak of beating earnings estimates at the previous two reports.
ZTS: 49.72 (-0.68)
Bear of the Day: Valeant Pharma (VRX)
Brian Hamilton - Zacks Investment Research - Thu Jul 14, 6:01AM CDT
Bear of the Day: Valeant Pharma (VRX)
ZTS: 49.72 (-0.68), VRX: 21.17 (+0.28), MDWD: 6.72 (-0.49)
7 Profitable Medical Stocks Ranked as Buys Now
Arpita Dutt - Zacks Investment Research - Tue Jun 21, 2:52PM CDT
It may be tough going for medical stocks but these 7 companies sporting a favorable Zacks Rank are poised to generate profits this year.
ZTS: 49.72 (-0.68), JNJ: 124.85 (-0.55), PFE: 36.39 (-0.92), LGND: 132.68 (-5.85), BMY: 75.05 (-1.14), AMPH: 16.17 (-0.12)
5 Top ROE Stocks for Improving Your Portfolio Returns
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 5:43AM CDT
With an enviable cash pile, these stocks appear to be enterprising picks when they are blended with attractive features like high ROE, high ROA and solid historical earnings growth along with a solid Zacks Rank.
ZTS: 49.72 (-0.68), BAK: 11.31 (-0.38), MO: 67.34 (-0.31), LEA: 109.11 (-4.55)